Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center.

Abstract

AIM To compare once- versus twice-daily insulin detemir added on OADS therapy in insulin-naive type 2 diabetes patients in terms of efficacy and safety. METHODS An open-label study performed at a single center, comprised a randomized, crossover 24 week with insulin-naive type 2 diabetes patients. Insulin detemir was initiated with mean 0.12 U/kg in all… (More)
DOI: 10.1016/j.pcd.2014.01.010

Topics

Cite this paper

@article{Cander2014ComparisonOE, title={Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center.}, author={Soner Cander and Oguzhan Sitki Dizdar and Ozen Oz Gul and Metin Guclu and Oğuz Kaan Unal and Ercan Tuncel and Erdinc Erturk and Sazi Imamoğlu and Canan Ersoy}, journal={Primary care diabetes}, year={2014}, volume={8 3}, pages={256-64} }